Let's ramble!

ali-flex RTU

After the coming of hospital’s contracted diseases such as C. difficile or MRSA (Methicilin-Resistant Staphylococcus Aureus), another difficult to treat bug seems to emerge. This time, it is a fungus: Candida auris.

This fungus or more precisely this yeast, has first been discovered by scientists in 1996. Then, a first infected human case has been reported in Japan in 2009. 1,2 To this date, Candida auris has been detected in hospitals of more than 20 countries such as the United States of America, England and many Europe countries. The first case in Canada has been reported in 20173.

Candida auris poses a specific threat because of the following characteristics4:

Infections by this microorganism have a high mortality rate.

The microorganism resists antifungal agents.

The microorganism is difficult to identify in clinical microbiology laboratories which results in wrong diagnostic. The identification is important in the choice of antifungal treatment.

The microorganism is known for its virulence.

The microorganism colonizes surfaces such as catheters used for healthcare.

Among recommended precautions by American and Canadian governments, disinfection of surfaces plays an important part. However, specific disinfectants are to avoid: this is notably the case for quaternary ammonium-based disinfectants which are ineffective5. The following procedure is rather recommended:

« Healthcare facilities that have patients with C. auris infection or colonization should ensure thorough daily and terminal cleaning and disinfection of these patient’s rooms with hospital-grade disinfectant effective against Clostridium difficile spores. »6

Sporicidal sodium hypochlorite-based disinfectant against C. difficile are for example great disinfectants to prevent and control contact transmission of Candida auris. In other words, scientists are only starting to understand and study this recently discovered microorganism. More studies will allow the discovery of effective treatment.

Until that time,in need of sporicidal products against C. Difficile to face Candidaauris new threat? Get our products right now!

Hospital beds are composed of many different parts: the bed frame, which includes the bed side rails, as well as a mattress and a mattress cover. Once a patient is discharged from the hospital, normally, the room will go through a substantial amount of cleaning, including the bed. The rails and bed frame will be wiped down and the bed cover will be changed in order to prepare for the next patient. However, one factor is often dismissed: the hospital bed mattress.

📷 pixabay.com

According to the ECRI Institute:

Bed and stretcher mattresses can remain contaminated after cleaning, putting patients and staff at risk of exposure to body fluids or microbiological contaminants. Reported incidents include patients lying on an apparently clean bed or stretcher when blood from a previous patient oozed out of the support surface onto the patient.

While hospital bed covers are changed regularly, many health care facilities fail to examine these bed covers for damages, heavy stains or tears. It is also important to note that mattress covers have an expected lifespan, and will become ineffective after this duration of time. All of these factors can lead to blood or any other body fluids leaking onto the hospital bed mattress, therefore leaving it contaminated.

The FDA (Food and Drug Administration) makes several recommendations in order to overcome this healthcare hazard:

Inspect

Remove and Replace

Maintain

Develop an Inspection Plan

While companies who sell the mattress covers have the responsibility in properly explaining to healthcare facilities how to properly disinfect, clean and dispose of bed covers, it is crucial for healthcare facilities to use the necessary materials and procedures in order to clean and disinfect. Healthcare facilities must also regularly inspect both mattress covers and mattresses in order to prevent infection as much as possible.

The Next Big Thing in Disinfection: Biofilm

Have you ever wondered what are the main factors affecting the efficacy of disinfection and sterilization in the healthcare facility? U.S. Centers for Disease Control and Prevention lists seven major causes of microbiological persistence on surfaces:

Number of microorganisms

Microbial resistance to biocides

Concentration and Potency of Disinfectants

Duration of Exposure

Chemical and Physical Factors

Presence of Organic or Inorganic Matter

Biofilms

For many experienced healthcare professionals, these factors are well known and often well dealt with. However, did you know the difference between soil (organic and inorganic matter) and biofilm? They both can significantly lower the efficacy of disinfection, but the biofilm is much harder to remove and control.

What is biofilm and how does it form?

Biofilm is an aggregation of microbial cells, surrounded by a protective layer of extracellular polymeric matrix, which attaches itself to any surface found in the hospital environment and becomes a source of contamination. Formation of complex, multicellular communities by microorganisms is a natural phenomenon which helps bacteria or fungi to survive environmental stress such as cleaning and disinfection.

Many pathogens require a presence of conditioning layer made from organic soil to settle and start extracellular matrix synthesis. But there are bacteria which don’t really need much help to start a biofilm community. When pathogens settle down and surround themselves in an extracellular polymeric substance (EPS), they are much harder to kill.

It has been reported that bacteria found in biofilm can be up to 1,000 times more resistant to biocides than their planktonic counterparts.

How to outsmart and fight biofilm?

Despite biofilms’ rigid structure and resistance mechanisms, biofilm cells can still be outsmarted. Since EPS is the ultimate protective barrier and communication route for pathogens, the control of biofilm should start with disruption of the EPS itself, followed by an application of a biocide.

In the actual market, you can find many cleaner-disinfectants. When it comes to consumer products, you’ll find a lot of brand, most of them are ready to use. It means you do not have to dilute the product and use it as is to disinfect. For industrial and institutionnal use, most of cleaner-disinfectants are concentrated if not ultra-concentrated. In that case, why choose a ready-to-use Bleach based Cleaner-Disinfectant for institutionnal use?

Main benefit of a low-foam concentrated product

Let’s talk about a product like Ali-Flex LF, a product like this one offers a high concentration for general disinfection in hospitals. On a day to day basis, with the right dilution system, the surfactants contained in ALI-FLEX LF increase the wetting power of this chlorinated disinfectant and contribute to degrease and remove dirt from hard non porous surfaces such as countertops, walls, floors, toilets, commode chairs, etc.

Main benefit of a ready-to-use chlorinated disinfectant cleaner

When it comes to infection control, one important aspect is to reduce the risk. We know that dilution systems can sometimes be flawed and not consistant with delivery concentration. Therefore, it is crucial to obtain a consistant known concentration. That is exactly what Ali-Flex RTU can provide: a factory consistant concentration of 6000 PPM (when packaged) with a validated shelf-life.

Of course it may generate more plastic in the environnement. Recycling may then be on option to consider. At the same time, when patient’s lifes are at risk, all factors that can reduce the risk is of important value.

What are you using in your facility?

Tell us what kind of product you are using. Are you in control? Are you facing problems when it comes to stop eclosion? Surely we can help you! Let’s talk!